Cuban Ambassador to China Ramirez Visits and Exchanges with Yinfeng Biotech Group
Release time:
2018-12-19
On December 19th, Cuban Ambassador to China Ramirez and his delegation visited and exchanged ideas at Yinfeng Biotech Group. Group President Song Xianshou and R&D Director Wang Zhihui accompanied the tour.

Mr. Ramirez and his delegation visited the Key Laboratory of Stem Cell Storage and Low Temperature Medicine under Yinfeng Biotechnology Group, and gained a detailed understanding of the achievements made by Yinfeng Biotechnology Group in scientific and technological innovation, transformation of scientific and technological achievements, and business development. Subsequently, both sides had exchanges and discussions.

Ambassador Ramirez expressed appreciation for the rapid development of Yinfeng Biotech Group. He said that Yinfeng Biotech Group has strong research and development capabilities, and in recent years, its overseas business has also achieved remarkable results. He hopes that Yinfeng Biotech Group can cooperate with relevant institutions in Cuba that have advantages in biopharmaceuticals. At the same time, the Cuban government strongly supports cross-border cooperation and welcomes Yinfeng Biotech Group to visit, exchange, and discuss cooperation in Cuba.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.